Fingerprint
Dive into the research topics of 'Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results
Sikander Ailawadhi, Ricardo D. Parrondo, Muhamad Alhaj Moustafa, Betsy R. LaPlant, Victoria Alegria, Dustin Chapin, Vivek Roy, Taimur Sher, Aneel Paulus, Asher A. Chanan-Khan
Research output: Contribution to journal › Article › peer-review